|
Name |
3,5,9-Trihydroxyergosta-7,22-diene-6-one
|
Molecular Formula | C28H44O4 | |
IUPAC Name* |
(9R,10R,13R,14R,17R)-17-[(2R,5R)-5,6-dimethylhept-3-en-2-yl]-3,5,9-trihydroxy-10,13-dimethyl-1,2,3,4,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-6-one
|
|
SMILES |
C[C@H](C=C[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@]3(C2=CC(=O)C4([C@@]3(CCC(C4)O)C)O)O)C
|
|
InChI |
InChI=1S/C28H44O4/c1-17(2)18(3)7-8-19(4)21-9-10-22-23-15-24(30)28(32)16-20(29)11-12-26(28,6)27(23,31)14-13-25(21,22)5/h7-8,15,17-22,29,31-32H,9-14,16H2,1-6H3/t18-,19+,20?,21+,22-,25+,26+,27+,28?/m0/s1
|
|
InChIKey |
GUERPVMWCQXYEU-QCFXBZKXSA-N
|
|
Synonyms |
3,5,9-trihydroxyergosta-7,22-diene-6-one
|
|
CAS | NA | |
PubChem CID | 91668420 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 444.6 | ALogp: | 4.5 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 32 | QED Weighted: | 0.52 |
Caco-2 Permeability: | -4.895 | MDCK Permeability: | 0.00002540 |
Pgp-inhibitor: | 0.15 | Pgp-substrate: | 0.027 |
Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.253 |
30% Bioavailability (F30%): | 0.713 |
Blood-Brain-Barrier Penetration (BBB): | 0.719 | Plasma Protein Binding (PPB): | 96.33% |
Volume Distribution (VD): | 1.248 | Fu: | 1.79% |
CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.879 |
CYP2C19-inhibitor: | 0.133 | CYP2C19-substrate: | 0.933 |
CYP2C9-inhibitor: | 0.218 | CYP2C9-substrate: | 0.077 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.077 |
CYP3A4-inhibitor: | 0.872 | CYP3A4-substrate: | 0.954 |
Clearance (CL): | 5.982 | Half-life (T1/2): | 0.322 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.026 |
Drug-inuced Liver Injury (DILI): | 0.099 | AMES Toxicity: | 0.029 |
Rat Oral Acute Toxicity: | 0.012 | Maximum Recommended Daily Dose: | 0.041 |
Skin Sensitization: | 0.354 | Carcinogencity: | 0.015 |
Eye Corrosion: | 0.013 | Eye Irritation: | 0.415 |
Respiratory Toxicity: | 0.567 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006035 | 1.000 | D0G8OC | 0.469 | ||||
ENC005610 | 1.000 | D06JPB | 0.456 | ||||
ENC004864 | 1.000 | D0G5CF | 0.448 | ||||
ENC006032 | 0.613 | D0N1TP | 0.366 | ||||
ENC004804 | 0.589 | D01QUS | 0.331 | ||||
ENC004757 | 0.589 | D08SVH | 0.323 | ||||
ENC004677 | 0.573 | D0Y7LD | 0.320 | ||||
ENC006033 | 0.570 | D0K5WS | 0.302 | ||||
ENC002327 | 0.560 | D02ZGI | 0.292 | ||||
ENC002206 | 0.555 | D0L2LS | 0.291 |